Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Preeclampsia
Research shows biomarkers may provide early warning for pregnancy complications
Researchers have identified biomarkers in blood samples that could provide an early warning system for three common and dangerous pregnancy complications.
January 12, 2023
Biora Therapeutics, Avero Diagnostics to develop preeclampsia rule-out test
Under the terms of an agreement, Biora would receive milestone payments and royalties on net sales if the test reaches the market.
November 29, 2022
Week in Review: Getting to know COVID-19 | Biomarkers for preeclampsia, liver disease | Quest puts HPV/Pap cotesting to the test
Dear LabPulse Member,
July 9, 2020
Blood biomarkers show risk for preeclampsia in pregnant women
The proof-of-concept study looked at the levels and ratio of the proteins FK506-binding protein like (FKBPL) and cluster of differentiation 44 (CD44) in plasma of pregnant women and matched normal controls at the Royal Jubilee Maternity Hospital in Belfast, U.K., and how they associated with risk for preeclampsia.
July 7, 2020
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Page 1 of 1
